Alpha 2.0
Login Register
» Authors » J O Kilburn

J O Kilburn

Explore the profile of J O Kilburn including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 1495
Followers 0
Related Specialties
Microbiology
Pulmonary Medicine
Pharmacology
Top 10 Co-Authors
W R Butler
G P KUBICA
V A Silcox
K Takayama
D E Snider Jr
E L Armstrong
R C Good
S W DOOLEY
C L Woodley
H L David
Published In
J Clin Microbiol
Am Rev Respir Dis
Antimicrob Agents Chemother
N Engl J Med
Am J Clin Pathol
Affiliations
Soon will be listed here.
Recent Articles
1.
Differentiation of Mycobacterium genavense and Mycobacterium simiae by automated mycolic acid analysis with high-performance liquid chromatography
Ritter D, CARLSON L, Logan B, Ramos L, Kilburn J, COYLE M
J Clin Microbiol . 1996 Aug; 34(8):2004-6. PMID: 8818899
Mycobacterium genavense, a fastidious opportunist in patients with AIDS, cannot be identified by conventional biochemical methods. Computerized mycolic acid analysis by high-performance liquid chromatography offers an alternative that distinguishes the...
2.
Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov
Springer B, Wu W, Bodmer T, Haase G, Pfyffer G, Kroppenstedt R, et al.
J Clin Microbiol . 1996 May; 34(5):1100-7. PMID: 8727884
A distinct group of slowly growing mycobacteria was identified on the basis of growth characteristics, biochemical and lipid profiles, and nucleic acid analyses. The isolates showed growth at 22 to...
3.
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents
Zurenko G, Yagi B, Schaadt R, Allison J, Kilburn J, Glickman S, et al.
Antimicrob Agents Chemother . 1996 Apr; 40(4):839-45. PMID: 8849237
Oxazolidinones make up a relatively new class of antimicrobial agents which possess a unique mechanism of bacterial protein synthesis inhibition. U-100592 (S)-N-[[3-[3-fluoro-4-[4-(hydroxyacetyl)-1-piperazinyl]- phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide and U-100766 (S)-N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]- 2-oxo-5-oxazolidinyl]methyl]-acetamide are novel oxazolidinone...
4.
Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity
Barbachyn M, Hutchinson D, Brickner S, Cynamon M, Kilburn J, Klemens S, et al.
J Med Chem . 1996 Feb; 39(3):680-5. PMID: 8576910
During the course of our investigations in the oxazolidinone antibacterial agent area, we have identified a subclass with especially potent in vitro activity against mycobacteria. The salient structural feature of...
5.
Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991
Valway S, Greifinger R, Papania M, Kilburn J, Woodley C, DiFerdinando G, et al.
J Infect Dis . 1994 Jul; 170(1):151-6. PMID: 8014491
Three epidemiologically linked multidrug-resistant (MDR) tuberculosis (TB) outbreaks in 1990-1991 involving New York State (NYS) inmates suggested MDR-TB was widespread in NYS prisons. Inmate lists were linked to 1990-1992 TB...
6.
Rapid identification of mycolic acid patterns of mycobacteria by high-performance liquid chromatography using pattern recognition software and a Mycobacterium library
Glickman S, Kilburn J, Butler W, Ramos L
J Clin Microbiol . 1994 Mar; 32(3):740-5. PMID: 8195387
Current methods for identifying mycobacteria by high-performance liquid chromatography (HPLC) require a visual assessment of the generated chromatographic data, which often involves time-consuming hand calculations and the use of flow...
7.
Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients
Straus W, Ostroff S, Jernigan D, Kiehn T, Sordillo E, Armstrong D, et al.
Ann Intern Med . 1994 Jan; 120(2):118-25. PMID: 8256970
Objective: To describe 13 infections caused by Mycobacterium haemophilum. Design: Identification of patients by microbiologic record review, followed by medical record review and a case-control study. Setting: Seven metropolitan hospitals...
8.
Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism
Wallace Jr R, Silcox V, Tsukamura M, Brown B, Kilburn J, Butler W, et al.
J Clin Microbiol . 1993 Dec; 31(12):3231-9. PMID: 8308116
Mycobacterium chelonae-like organisms are nonpigmented rapidly growing mycobacteria whose clinical significance is unknown. We evaluated 87 sporadic isolates encountered in a clinical laboratory. Most isolates (62%) were respiratory; only 2...
9.
Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis
Coronado V, Hutton M, Davis B, Nicholas P, Villareal C, Woodley C, et al.
J Infect Dis . 1993 Oct; 168(4):1052-5. PMID: 8104226
From January 1990 to December 1991, 16 patients with multidrug-resistant tuberculosis (MDR-TB) caused by Mycobacterium tuberculosis resistant to isoniazid, rifampin, and streptomycin were diagnosed at Elmhurst Hospital. Compared with other...
10.
Mycobacterium celatum sp. nov
Butler W, OConnor S, Yakrus M, Smithwick R, Plikaytis B, MOSS C, et al.
Int J Syst Bacteriol . 1993 Jul; 43(3):539-48. PMID: 8102246
A new slowly growing nonphotochromogenic Mycobacterium species of clinical importance is described. The biochemical characteristics of this organism were similar to those of Mycobacterium xenopi and members of the Mycobacterium...